Yale Innovation Summit 2024

Affiliated Programs

Wednesday, May 29, 2024 - Thursday, May 30, 2024

165 Whitney Ave
New Haven, CT

The Yale Innovation Summit, Sponsored by Wilson Sonsini Goodrich & Rosati, convenes the innovation and entrepreneurship community for two days of impactful conversations, purposeful networking, and Yale pitch competition across five tracks of programming. Celebrating its 10th year, the event has become one of the region’s biggest and most impactful innovation events, drawing investors, founders, and industry partners to Yale’s campus from around the world to create new connections and opportunities. Five tracks of programming will each feature keynotes, panel discussions, and pitch competitions in the arts, biotech, climate, health, and technology. This year’s event theme will focus on the event’s ten-year anniversary milestone, the transformational potential of AI, and the evolution of Yale and New Haven as a “next great innovation hub.”

Biotech Panel – Trends in Biotech and Pharma (May 30 – 10:15-11:15 AM)
Sponsored by Wilson Sonsini & hosted by Boston partner Chris McAndrew

Pitch Competition: Health Company Presentations (May 30 – 1:00-3:15 PM)
Moderated by Wilson Sonsini partner Eva Yin

Contacts

Nicolas Baird

nbaird@wsgr.com

Presenters

Chris W. McAndrew

Partner

Boston

Chris represents life sciences clients in patent and related IP matters.

View Profile

Eva F. Yin

Partner

Seattle

Eva Yin, Ph.D., M.P.H., is a partner in Wilson Sonsini Goodrich & Rosati’s FDA regulatory, healthcare, and consumer products practice. Her practice includes conducting FDA and healthcare regulatory due diligence for corporate transactions; providing legal counsel to manufacturers regarding FDA approval/clearance for various products—including medical devices, mobile apps, and drugs, FDA compliance, regulation of promotional materials and labeling, and manufacturer compliance under federal and state healthcare laws, e.g., the federal Anti-Kickback Statute (AKS), False Claims Act (FCA), Sunshine Act, state licensing laws, corporate practice of medicine, etc.; reviewing contracts and compliance policies for manufacturers; and providing legal analysis and risk assessment of business models and fee arrangements involving patient assistance programs, healthcare professionals, or hospitals/clinics under federal and state healthcare laws and regulations.